1. Guest, 'News In Brief' from w/c 3rd Dec can be read here.
    Dismiss Notice

Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome

Discussion in 'Health News and Research unrelated to ME/CFS' started by Milo, Jan 20, 2018.

  1. Milo

    Milo Senior Member (Voting Rights)

    Messages:
    370
    Likes Received:
    2,737
    Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome

    Abstract:

    Rationale: Orthostatic hypotension is a common clinical problem, but the underlying mechanisms have not been fully delineated.

    Objective: We describe two families, with four patients in total, suffering from severe life-threatening orthostatic hypotension due to a novel cause.

    Methods and Results:

    As in dopamine β-hydroxylase deficiency (DβH), concentrations of norepinephrine and epinephrine in the patients were very low.

    Plasma DβH activity, however, was normal and the DBH gene had no mutations.

    Molecular genetic analysis was performed to determine the underlying genetic cause.

    Homozygosity mapping and exome and Sanger sequencing revealed pathogenic homozygous mutations in the gene encoding cytochrome b561 (CYB561); a missense variant c.262G>A, p.Gly88Arg in exon 3 in the Dutch family and a nonsense mutation (c.131G>A, p.Trp44*) in exon 2 in the American family.

    Expression of CYB561 was investigated using RNA from different human adult and fetal tissues, transcription of RNA into cDNA and real-time quantitative polymerase chain reaction.

    The CYB561 gene was found to be expressed in many human tissues, in particular the brain.

    The CYB561 protein defect leads to a shortage of ascorbate inside the catecholamine secretory vesicles leading to a functional DβH deficiency.

    The concentration of the catecholamines and downstream metabolites was measured in brain and adrenal tissue of six CYB561 knockout mice (reporter-tagged deletion allele (post-Cre), genetic background C57BL/6NTac).

    The concentration of norepinephrine and normetanephrine was decreased in whole brain homogenates of the CYB561(-/-) mice compared to wild type mice (p<0.01) and the concentration of normetanephrine and metanephrine was decreased in adrenal glands (p<0.01), recapitulating the clinical phenotype.

    The patients responded favorably to treatment with L-dihydroxyphenylserine, which can be converted directly to norepinephrine.

    Conclusions:

    This study is the first to implicate cytochrome b561 in disease by showing that pathogenic mutations in CYB561 cause an as yet unknown disease in neurotransmitter metabolism causing orthostatic hypotension. as yet unknown disease in neurotransmitter metabolism causing orthostatic hypotension

    Link to paper (there is a paywall) http://circres.ahajournals.org/content/early/2018/01/16/CIRCRESAHA.117.311949.long

     
    ScottTriGuy, Mij and Valentijn like this.

Share This Page